Ocular Therapeutix, Inc. (OCUL)
9.82
-0.18
(-1.80%)
USD |
NASDAQ |
Sep 24, 16:00
9.82
0.00 (0.00%)
After-Hours: 19:59
Ocular Therapeutix Gross Profit (Annual) : 45.38M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 45.38M |
| December 31, 2024 | 58.10M |
| December 31, 2023 | 53.16M |
| December 31, 2022 | 46.95M |
| December 31, 2021 | 39.12M |
| December 31, 2020 | 13.93M |
| December 31, 2019 | 0.637M |
| Date | Value |
|---|---|
| December 31, 2018 | -0.761M |
| December 31, 2017 | -0.159M |
| December 31, 2016 | 1.004M |
| December 31, 2015 | 0.677M |
| December 31, 2014 | 0.134M |
| December 31, 2013 | -0.404M |
| December 31, 2012 | -0.401M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| EyePoint, Inc. | 27.00M |
| Theravance Biopharma, Inc. | 101.95M |
| LENZ Therapeutics, Inc. | 18.38M |
| ANI Pharmaceuticals, Inc. | 450.64M |
| Corcept Therapeutics, Inc. | 748.43M |